Abstract: This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using N-linked sulfonamides of heterocyclic thioesters.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
August 12, 2008
Assignee:
GPI Nil Holdings Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using heterocyclic thioesters and ketones.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
May 7, 2002
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance in an animal using small molecule sulfonamides.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
December 25, 2001
Assignee:
Gpi Nil Holdings, Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance in an animal, using pipecolic acid derivatives.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
January 1, 2002
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to novel compositions and uses of N-heterocyclic carboxylic acids and carboxylic acid isosteres for treating a vision disorder, improving vision, treating memory impairment or enhancing memory performance in an animal.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
September 4, 2007
Assignee:
GPI NIL Holdings Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to a method of using neurotrophic low molecular weight, small molecule piperidine and pyrrolidine sulfonamide compounds having an affinity for FKBP-type immunophilins, as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
February 23, 1998
Date of Patent:
October 19, 1999
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Jia-He Li, Joseph P. Steiner
Abstract: This invention relates to a method of using neurotrophic low molecular weight, small molecule sulfonamide compounds having an affinity for FKBP-type immunophilins, as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
February 12, 1997
Date of Patent:
February 24, 1998
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Jia-He Li, Joseph P. Steiner
Abstract: This invention relates to neurotrophic N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity.
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-linked ureas and carbamates of heterocyclic thioesters having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
December 31, 1996
Date of Patent:
August 10, 1999
Assignee:
GPI NIL Holdings Inc.
Inventors:
Gregory S. Hamilton, Jia-He Li, Wei Huang
Abstract: The present invention relates to pharmaceutical compositions comprising and methods of using an N-linked urea or carbamate of a heterocyclic thioester for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
January 14, 2003
Assignee:
GPI Nil Holdings, Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to a method of using neurotrophic low molecular weight, small molecule sulfonamide compounds having an affinity for FKBP-type immunophilins, as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
October 18, 1999
Date of Patent:
June 12, 2001
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Jia-He Li, Joseph P. Steiner
Abstract: This invention relates to novel N-heterocyclic carboxylic acids and carboxylic acid isosteres, their preparation and use for treating neurological disorders including physically damaged nerves and neurodegenerative diseases, for treating alopecia and promoting hair growth, for treating vision disorders and/or improving vision, and for treating memory impairment and/or enhancing memory performance by administering such compounds.
Type:
Grant
Filed:
August 2, 2001
Date of Patent:
December 26, 2006
Assignee:
GPI NIL Holdings Inc.
Inventors:
Gregory S. Hamilton, Mark H. Norman, Yong-Qian Wu
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
July 9, 1998
Date of Patent:
April 25, 2000
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
April 26, 2001
Date of Patent:
November 26, 2002
Assignee:
GPI NIL Holdings Inc.
Inventors:
Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
Abstract: This invention relates to novel compositions and uses of a N-linked sulfonamide of an N-heterocylic carboxylic acid or isostere thereof for treating a vision disorder or improving vision or treating memory impairment or enhancing memory performance in an animal.
Type:
Grant
Filed:
August 14, 1998
Date of Patent:
January 15, 2002
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Douglas T. Ross, Hansjörg Sauer, Gregory S. Hamilton, Joseph P. Steiner
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-linked sulfonamides of heterocyclic thioesters having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
December 31, 1996
Date of Patent:
February 23, 1999
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Jia-He Li, Wei Huang
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Grant
Filed:
April 21, 2000
Date of Patent:
June 26, 2001
Assignee:
GPI NIL Holdings, Inc.
Inventors:
Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-linked sulfonamides of heterocyclic thioesters having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
Type:
Application
Filed:
August 10, 2001
Publication date:
April 25, 2002
Applicant:
GPI NIL HOLDINGS, INC.
Inventors:
Gregory S. Hamilton, Jai-He Li, Wei Huang
Abstract: This invention relates to the method of using specially formulated neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity to stimulate or promote neuronal growth or regeneration.
Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Type:
Application
Filed:
August 29, 2013
Publication date:
March 6, 2014
Inventors:
Stefan SCHUNK, Melanie REICH, Henning STEINHAGEN, Nils DAMANN, Michael HAURAND, Achim KLESS, Philip SKONE, Richard HAMLYN, Robert KIRBY, Marc ROGERS, Kathy SUTTON